Fed. Circ. Lifts Block On Generic Lovenox Sales
Amphastar and Watson plan to launch a competing enoxaparin sodium injection product immediately, according to a statement from Watson.
Cambridge, Mass.-based Momenta and partner Novartis AG are currently the only companies that market a generic version of Sanofi SA's Lovenox in the U.S.
On Tuesday, attorneys...
To view the full article, register now.